tiprankstipranks
Illumina (CH:ILU)
:ILU
Switzerland Market

Illumina (ILU) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

ILU Analyst Ratings

Moderate Buy
16Ratings
Moderate Buy
8 Buy
5 Hold
3 Sell
Based on 16 analysts giving stock ratings to
Illumina
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ILU Stock 12 Month Forecast

Average Price Target

Based on 16 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is CHF155.86 with a high forecast of CHF186.28 and a low forecast of CHF91.52. The average price target represents a change from the last price of .
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
Highest Price TargetCHF186.28Average Price TargetCHF155.86Lowest Price TargetCHF91.52
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on CH:ILU
RBC Capital
RBC Capital
CHF186.28
Buy
Reiterated
08/10/26
Analysts Are Bullish on Top Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), Surgery Partners (SGRY)
Bank of America Securities Analyst forecast on CH:ILU
Bank of America Securities
Bank of America Securities
CHF113.39
Sell
Reiterated
08/05/26
Illumina: One-Time Consumables Boost Masks Weak Underlying Demand; Sell Rating Reiterated with Unchanged $140 Price Target
Freedom Capital Markets Analyst forecast on CH:ILU
Freedom Capital Markets
Freedom Capital Markets
CHF125.54CHF149.84
Hold
Downgraded
08/05/26
Illumina downgraded to Hold from Buy at Freedom BrokerIllumina downgraded to Hold from Buy at Freedom Broker
Stifel Nicolaus Analyst forecast on CH:ILU
Stifel Nicolaus
Stifel Nicolaus
CHF182.23
Buy
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
J.P. Morgan Analyst forecast on CH:ILU
J.P. Morgan
J.P. Morgan
CHF186.28
Buy
Reiterated
08/04/26
J.P. Morgan Keeps Their Buy Rating on Illumina (ILMN)
Piper Sandler Analyst forecast on CH:ILU
Piper Sandler
Piper Sandler
CHF161.99CHF182.23
Buy
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and InspireMD (NASDAQ: NSPR)
Canaccord Genuity Analyst forecast on CH:ILU
Canaccord Genuity
Canaccord Genuity
CHF153.89CHF166.03
Hold
Reiterated
08/03/26
Canaccord Genuity Remains a Hold on Illumina (ILMN)
Citi
CHF76.94CHF91.52
Sell
Reiterated
08/03/26
Illumina price target raised to $113 from $95 at CitiIllumina price target raised to $113 from $95 at Citi
TD Cowen
CHF155.51CHF170.08
Hold
Assigned
07/31/26
TD Cowen Keeps Their Hold Rating on Illumina (ILMN)
Barclays Analyst forecast on CH:ILU
Barclays
Barclays
CHF117.44CHF129.59
Sell
Reiterated
07/31/26
Barclays Sticks to Its Sell Rating for Illumina (ILMN)
Bernstein Analyst forecast on CH:ILU
Bernstein
Bernstein
CHF149.84CHF174.13
Hold
Reiterated
07/31/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (NASDAQ: ILMN), Dyne Therapeutics (NASDAQ: DYN) and Bristol-Myers Squibb (NYSE: BMY)
Guggenheim Analyst forecast on CH:ILU
Guggenheim
Guggenheim
CHF161.99CHF183.04
Buy
Reiterated
07/30/26
Illumina price target raised to $226 from $200 at GuggenheimIllumina price target raised to $226 from $200 at Guggenheim
Leerink Partners Analyst forecast on CH:ILU
Leerink Partners
Leerink Partners
CHF141.74CHF170.08
Buy
Reiterated
07/17/26
Analysts' Top Healthcare Picks: Insmed (INSM), Illumina (ILMN)
Evercore ISI Analyst forecast on CH:ILU
Evercore ISI
Evercore ISI
CHF125.54CHF161.99
Buy
Reiterated
07/06/26
Illumina price target raised to $200 from $155 at Evercore ISIIllumina price target raised to $200 from $155 at Evercore ISI
Jefferies
CHF121.49
Hold
Reiterated
07/01/26
Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT), Illumina (NASDAQ: ILMN) and Protara Therapeutics (NASDAQ: TARA)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on CH:ILU
RBC Capital
RBC Capital
CHF186.28
Buy
Reiterated
08/10/26
Analysts Are Bullish on Top Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), Surgery Partners (SGRY)
Bank of America Securities Analyst forecast on CH:ILU
Bank of America Securities
Bank of America Securities
CHF113.39
Sell
Reiterated
08/05/26
Illumina: One-Time Consumables Boost Masks Weak Underlying Demand; Sell Rating Reiterated with Unchanged $140 Price Target
Freedom Capital Markets Analyst forecast on CH:ILU
Freedom Capital Markets
Freedom Capital Markets
CHF125.54CHF149.84
Hold
Downgraded
08/05/26
Illumina downgraded to Hold from Buy at Freedom BrokerIllumina downgraded to Hold from Buy at Freedom Broker
Stifel Nicolaus Analyst forecast on CH:ILU
Stifel Nicolaus
Stifel Nicolaus
CHF182.23
Buy
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
J.P. Morgan Analyst forecast on CH:ILU
J.P. Morgan
J.P. Morgan
CHF186.28
Buy
Reiterated
08/04/26
J.P. Morgan Keeps Their Buy Rating on Illumina (ILMN)
Piper Sandler Analyst forecast on CH:ILU
Piper Sandler
Piper Sandler
CHF161.99CHF182.23
Buy
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and InspireMD (NASDAQ: NSPR)
Canaccord Genuity Analyst forecast on CH:ILU
Canaccord Genuity
Canaccord Genuity
CHF153.89CHF166.03
Hold
Reiterated
08/03/26
Canaccord Genuity Remains a Hold on Illumina (ILMN)
Citi
CHF76.94CHF91.52
Sell
Reiterated
08/03/26
Illumina price target raised to $113 from $95 at CitiIllumina price target raised to $113 from $95 at Citi
TD Cowen
CHF155.51CHF170.08
Hold
Assigned
07/31/26
TD Cowen Keeps Their Hold Rating on Illumina (ILMN)
Barclays Analyst forecast on CH:ILU
Barclays
Barclays
CHF117.44CHF129.59
Sell
Reiterated
07/31/26
Barclays Sticks to Its Sell Rating for Illumina (ILMN)
Bernstein Analyst forecast on CH:ILU
Bernstein
Bernstein
CHF149.84CHF174.13
Hold
Reiterated
07/31/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (NASDAQ: ILMN), Dyne Therapeutics (NASDAQ: DYN) and Bristol-Myers Squibb (NYSE: BMY)
Guggenheim Analyst forecast on CH:ILU
Guggenheim
Guggenheim
CHF161.99CHF183.04
Buy
Reiterated
07/30/26
Illumina price target raised to $226 from $200 at GuggenheimIllumina price target raised to $226 from $200 at Guggenheim
Leerink Partners Analyst forecast on CH:ILU
Leerink Partners
Leerink Partners
CHF141.74CHF170.08
Buy
Reiterated
07/17/26
Analysts' Top Healthcare Picks: Insmed (INSM), Illumina (ILMN)
Evercore ISI Analyst forecast on CH:ILU
Evercore ISI
Evercore ISI
CHF125.54CHF161.99
Buy
Reiterated
07/06/26
Illumina price target raised to $200 from $155 at Evercore ISIIllumina price target raised to $200 from $155 at Evercore ISI
Jefferies
CHF121.49
Hold
Reiterated
07/01/26
Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT), Illumina (NASDAQ: ILMN) and Protara Therapeutics (NASDAQ: TARA)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
ACRVAcrivon Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
TNYATenaya Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Illumina

3 Months
Success Rate
11/17 ratings generated profit
65%
Average Return
>-0.01%
Copying Patrick B Donnelly's trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of >-0.01% per trade.
1 Year
Success Rate
10/17 ratings generated profit
59%
Average Return
-7.86%
Copying Patrick B Donnelly's trades and holding each position for 1 Year would result in 58.82% of your transactions generating a profit, with an average return of -7.86% per trade.
2 Years
Puneet SoudaLeerink Partners
Success Rate
19/31 ratings generated profit
61%
Average Return
+26.29%
Copying Puneet Souda's trades and holding each position for 2 Years would result in 61.29% of your transactions generating a profit, with an average return of +26.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ILU Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
6
6
9
16
15
Hold
11
6
4
9
9
Sell
5
6
6
7
5
Strong Sell
0
0
0
0
0
total
22
18
19
32
29
In the current month, ILU has received 15 Buy Ratings, 9 Hold Ratings, and 5 Sell Ratings. ILU average Analyst price target in the past 3 months is 155.86.
Each month's total comprises the sum of three months' worth of ratings.

ILU Financial Forecast

ILU Earnings Forecast

Next quarter’s earnings estimate for ILU is CHF1.10 with a range of CHF1.08 to CHF1.12. The previous quarter’s EPS was CHF1.06. ILU beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ILU has Performed in-line its overall industry.
Next quarter’s earnings estimate for ILU is CHF1.10 with a range of CHF1.08 to CHF1.12. The previous quarter’s EPS was CHF1.06. ILU beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ILU has Performed in-line its overall industry.

ILU Sales Forecast

Next quarter’s sales forecast for ILU is CHF935.83M with a range of CHF926.06M to CHF941.48M. The previous quarter’s sales results were CHF942.29M. ILU beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ILU has Performed in-line its overall industry.
Next quarter’s sales forecast for ILU is CHF935.83M with a range of CHF926.06M to CHF941.48M. The previous quarter’s sales results were CHF942.29M. ILU beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ILU has Performed in-line its overall industry.

ILU Stock Forecast FAQ

What is CH:ILU’s average 12-month price target, according to analysts?
Based on analyst ratings, Illumina’s 12-month average price target is 155.86.
    What is CH:ILU’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:ILU, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Illumina a Buy, Sell or Hold?
        Illumina has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 5 hold ratings and 3 sell ratings.
          What is Illumina’s share price target?
          The average share price target for Illumina is 155.86. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF186.28 ,and the lowest forecast is CHF91.52. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Illumina?
            Illumina’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.
              How can I buy shares of Illumina?
              To buy shares of CH:ILU, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.